Back to results
US 8,278,420 B2Granted
Composition and method for prevention and treatment of type I diabetes
AssigneeQinghua Wang
InventorsQinghua Wang, Gerald J. Prud'homme, Mohan Kumar
Life of this patent
Estimating the term…
Abstract
A composition for the prevention or treatment of type I diabetes in a subject, said composition comprising a fusion protein selected from the group consisting of GLP-1/IgG or variant or fragment thereof and an Ex4/IgG or variant or fragment thereof and an autoimmune suppressor for silencing an autoimmune response against islet beta cells.
Claims4
A composition for the treatment of type I diabetes in a subject, said composition comprising:
- a GLP-1/IgG fusion protein, wherein said GLP-1 polypeptide is selected from the group consisting of GLP-1(7-37)OH, GLP-1(7-36)amide (SEQ ID NO:1), a DPPIV resistant GLP-1 Ala8 mutant and a DPPIV resistant GLP-1 His7 mutant;
- and the IgG is human IgG2:
- and
- an autoimmune suppressor comprising at least one antigenic target epitope of a pancreatic beta-cell associated antigen for decreasing autoimmunity against islet beta cells, wherein said pancreatic beta-cell associated antigen is pre-proinsulin comprising SEQ ID NO:8, GAD65 comprising SEQ ID NO:9, 10 and/or 11, or pre-proinsulin/GAD65 (PPI/GAD65) comprising SEQ ID NO:8 and SEQ ID NO:
- 9, 10 and/or 11.
2 more elements
Dependencies are inferred from the claim text.